Title
Oral Nipah Vaccine
CoPED ID
62af5057-142d-4970-8d74-e4c959063acc
Status
Active
Funder
Value
£288,608
Start Date
March 31, 2022
End Date
March 30, 2023
Description
IosBio has developed a technology which enables the generation of thermally stable, orally administered vaccines. We will utilise this technology to develop a candidate Nipah vaccine, a disease identified as having pandemic potential.
Iosbio Ltd | LEAD_ORG |
Iosbio Ltd | PARTICIPANT_ORG |
Andrew BACON | PM_PER |
Subjects by relevance
- Vaccines
- Pandemics
- Technological development
- Technology
- Diseases
- Vaccination
- History
- Communicable diseases
Extracted key phrases
- Candidate Nipah vaccine
- Oral Nipah Vaccine
- Technology
- Generation
- IosBio
- Stable
- Disease
- Pandemic potential